Compare · FLNC vs TMO
FLNC vs TMO
Side-by-side comparison of Fluence Energy Inc. (FLNC) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- FLNC operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $179.14B, about 45.0x FLNC ($3.98B).
- Over the past year, FLNC is up 338.8% and TMO is up 16.1% - FLNC leads by 322.7 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 11 for FLNC).
- Both have 25 recent analyst ratings on file.
- Company
- Fluence Energy Inc.
- Thermo Fisher Scientific Inc
- Price
- $21.64-7.78%
- $482.27-2.41%
- Market cap
- $3.98B
- $179.14B
- 1M return
- -14.28%
- +6.57%
- 1Y return
- +338.84%
- +16.13%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 11
- 17
- Recent ratings
- 25
- 25
Fluence Energy Inc.
Fluence Energy, Inc. provides energy storage products and services, and digital applications for renewables and storage applications worldwide. The company sells energy storage products with integrated hardware, software, and digital intelligence, as well as engineering and delivery services to support the deployment of its storage products; operational and maintenance, and energy storage-as-a-service; and digital applications and solutions. It serves utilities, developers, and commercial and industrial customers. The company was founded in 2018 and is headquartered in Arlington, Virginia. Fluence Energy, LLC operates as a subsidiary of Siemens Aktiengesellschaft and The AES Corporation.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest FLNC
- DNV Validates Fluence 99% Fleet Performance Availability for Large Energy Storage Projects
- SEC Form 3 filed by new insider Da Santos Bernerd
- Fluence Energy Inc. filed SEC Form 8-K: Leadership Update
- Director Fessenden Elizabeth Anne gifted 1,000 shares, decreasing direct ownership by 1% to 66,250 units (SEC Form 4)
- SEC Form SD filed by Fluence Energy Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Fluence Energy Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Fluence Energy Inc.
- Large owner Aes Corp converted options into 10,066,414 shares and sold $211,394,694 worth of shares (10,066,414 units at $21.00) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Fluence Energy Inc.
- Large owner Qatar Investment Authority sold $60,210,612 worth of shares (2,867,172 units at $21.00) (SEC Form 4)
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)